Ligand backs Castle Creek’s gene therapy with $75 million investment By Investing.com

Published: 02/25/2025

Ligand backs Castle Creek’s gene therapy with $75 million investment By Investing.com

tags

Latest News

NEWS 02.12.2026

New modern theatre complex at Matunda Hospital ready for commissioning — Natembeya – MSN

NEWS 02.12.2026

Diabetic Foot Ulcers Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Medline, B. Braun, Organogenesis, 3M, Smith & Nephew, Molnlycke Health Care, ConvaTec – Barchart.com

NEWS 02.12.2026

Non-opioid pain pill and gene therapy help fuel Vertex’s $12B year – Stock Titan

NEWS 02.12.2026

CRISPR Therapeutics AG SEC 10-K Report – TradingView